T1	Condition 25 33	Pregnant
E1	Condition:T1 Name:T30
T2	And 40 43	who
E2	And:T2 Arg:T31 Arg2:E3
T3	Condition 64 67	GDM
E3	Condition:T3 Name:T32
T4	Eq-Comparison 73 83	13 to 32.6
E4	Eq-Comparison:T4 Value:T33 Operator:T34 Value:T35 Temporal-Unit:T37
T5	Observation 84 95	gestational
E5	Observation:T5 Name:T36 Eq-Comparison:E4
T8	Modifier 135 144	Singleton
E8	Modifier:T8 Modifies:T41
T9	Condition 145 154	pregnancy
E9	Condition:T9 Name:T41
T10	And 186 190	with
E10	And:T10 Arg:T42 Arg2:E12
T12	Condition 207 224	diabetes mellitus
E12	Condition:T12 Name:T44
T13	Condition 230 233	GDM
E13	Condition:T13 Name:T45
T14	Eq-Comparison 244 248	≥ 33
E14	Eq-Comparison:T14 Operator:T46 Value:T47 Temporal-Unit:T49
T15	Observation 249 260	gestational
E15	Observation:T15 Name:T48 Eq-Comparison:E14
T17	Eq-Comparison 278 283	using
E17	Eq-Comparison:T17 Temporal-Period:T51
T19	Procedure 284 320	prophylactic antimicrobial treatment
E19	Procedure:T19 Name:T16 Temporality:E17
T20	Condition 326 343	Immunocompromised
E20	Condition:T20 Name:T53
T21	Eq-Comparison 355 363	Multiple
E21	Eq-Comparison:T21 Operator:T55
T22	Condition 364 373	pregnancy
E22	Condition:T22 Name:T56 Minimum-Count:E21
T23	Eq-Comparison 385 391	taking
E23	Eq-Comparison:T23 Temporal-Period:T58
T24	Drug 397 415	probiotic products
E24	Drug:T24 Name:T59 Temporality:E23
T25	And 416 419	who
E25	And:T25 Arg:E24 Arg2:E26
T26	Assertion 420 429	refuse to
E26	Assertion:T26 Asserted:E18
A1	Assertion-Type-Value E26 hypothetical
T27	Coreference 435 450	the consumption
E27	Coreference:T27 Refers-To:E24
T30	Condition-Name 25 33	Pregnant
T31	Life-Stage-And-Gender 34 39	women
A2	Life-Stage-And-Gender-Type T31 female
T32	Condition-Name 64 67	GDM
T33	Eq-Value 73 75	13
T34	Eq-Operator 76 78	to
A3	Eq-Operator-Value T34 BETWEEN
T35	Eq-Value 79 83	32.6
T36	Observation-Name 84 95	gestational
T37	Eq-Temporal-Unit 96 101	weeks
A4	Eq-Temporal-Unit-Value T37 week
T38	Eq-Value 107 109	18
T39	Eq-Temporal-Unit 110 115	years
A5	Eq-Temporal-Unit-Value T39 year
T40	Eq-Operator 120 129	and older
A6	Eq-Operator-Value T40 GTEQ
T41	Condition-Name 145 154	pregnancy
T42	Life-Stage-And-Gender 180 185	Women
A7	Life-Stage-And-Gender-Type T42 female
T44	Condition-Name 207 224	diabetes mellitus
T45	Condition-Name 230 233	GDM
T46	Eq-Operator 244 245	≥
A9	Eq-Operator-Value T46 GTEQ
T47	Eq-Value 246 248	33
T48	Observation-Name 249 260	gestational
T49	Eq-Temporal-Unit 261 266	weeks
A10	Eq-Temporal-Unit-Value T49 week
T50	Life-Stage-And-Gender 272 277	Women
A11	Life-Stage-And-Gender-Type T50 female
T51	Eq-Temporal-Period 278 283	using
A12	Eq-Temporal-Period-Value T51 present
T53	Condition-Name 326 343	Immunocompromised
T54	Life-Stage-And-Gender 344 349	women
A13	Life-Stage-And-Gender-Type T54 female
T55	Eq-Operator 355 363	Multiple
A14	Eq-Operator-Value T55 GT
T56	Condition-Name 364 373	pregnancy
T57	Life-Stage-And-Gender 379 384	Women
A15	Life-Stage-And-Gender-Type T57 female
T58	Eq-Temporal-Period 385 391	taking
A16	Eq-Temporal-Period-Value T58 present
T59	Drug-Name 397 415	probiotic products
A17	Observation-Type-Value T36 measurement
T6	Eq-Comparison 107 129	18 years old and older
E6	Eq-Comparison:T6 Value:T38 Temporal-Unit:T39 Operator:T40
T7	Age 124 129	older
E7	Age:T7 Eq-Comparison:E6
T11	Modifier 191 206	pre-gestational
E11	Modifier:T11 Modifies:T44
T43	Temporal-Connection 68 72	from
E30	Temporal-Connection:T43 Arg:E3 Arg2:E5
A8	Temporal-Connection-Type-Value E30 during
A18	Observation-Type-Value T48 measurement
T16	Procedure-Name 284 320	prophylactic antimicrobial treatment
R1	If-Then Arg1:T50 Arg2:E19	
R2	If-Then Arg1:E20 Arg2:T54	
R3	If-Then Arg1:T57 Arg2:E24	
T18	Modifier 392 396	oral
E16	Modifier:T18 Modifies:T59
T52	Negation 430 434	stop
E18	Negation:T52 Negates:E27
T28	Drug 468 478	probiotics
E28	Drug:T28 Name:T29
T29	Drug-Name 468 478	probiotics
T60	Modifier 452 467	food-containing
E29	Modifier:T60 Modifies:T29
T61	Exception 482 496	not considered
E31	Exception:T61 From:E24 Except:E28
